Evidence map›Paper›PMID 40130305›Full record

ArticleCirculation. Genomic and precision medicine2025

Many Journeys Originating at the Same Source to Arrive at Solutions to the Common Problem of High Lipoprotein(a).

Jean Woody Luxama, Joshua W Knowles

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation. Genomic and precision medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jean Woody LuxamaCollege of Medicine, University of Central Florida, Orlando (J.W.L.).ORCID 0009-0001-4166-1716
Joshua W KnowlesStanford Division of Cardiology, Cardiovascular Institute, Prevention Research Center, Stanford, CA (J.W.K.).ORCID 0000-0003-1922-7240

Funding

Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studiesR01DK120565 · NIDDK · STANFORD UNIVERSITY · PI KNOWLES, JOSHUA WILEY · 2019 to 2023
$3.2M
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial DysfunctionR01DK116750 · NIDDK · STANFORD UNIVERSITY · PI KNOWLES, JOSHUA WILEY · 2019 to 2023
$2.4M
Beyond GWAS of insulin resistance: An integrated approach to translate genetic association to functionR01DK106236 · NIDDK · STANFORD UNIVERSITY · PI KNOWLES, JOSHUA WILEY · 2016 to 2020
$2.4M
Molecular Mechanisms of Insulin Resistance Associated LociR01DK137889 · NIDDK · STANFORD UNIVERSITY · PI Joshua Wiley Knowles · 2024 to 2026
$1.8M
Stanford Cardiovascular Summer Research Training Program for Medical StudentsT35HL160496 · NHLBI · STANFORD UNIVERSITY · PI America Facundo, Joseph C. Wu · 2022 to 2026
$574k
Synergizing Common Fund Data from MoTrPAC and LINCS for the Discovery of Novel Exercise Mimetic DrugsR03OD038388 · OD · STANFORD UNIVERSITY · PI KNOWLES, JOSHUA WILEY · 2024 to 2024
$309k
NHLBI NIH HHS T35 HL160496NIDDK NIH HHS P30 DK116074NIDDK NIH HHS R01 DK106236NIDDK NIH HHS R01 DK116750NIDDK NIH HHS R01 DK120565NIDDK NIH HHS R01 DK137889NIH HHS R03 OD038388
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atherosclerosischolesterolEditorialsgenomicsgoalsstroke

Identifiers

PMID40130305
PMCPMC11999797

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.